Literature DB >> 33507488

Imatinib and nutritional support can make successful treatment for a case of huge liver metastasis of duodenal gastrointestinal stromal tumor that initially showed jaundice and cachexia.

Yumeo Tateyama1, Atsushi Naganuma1, Yuhei Suzuki1, Tomoyuki Masuda1, Sanae Uehara1, Takashi Hoshino1, Hidetoshi Yasuoka1, Tomohiro Kudo1, Yusuke Ogawa2, Tetsushi Ogawa3, Kohei Tateno4, Norihiro Ishii4, Kenichiro Araki4, Norifumi Harimoto4, Ken Shirabe4, Satoru Kakizaki5,6.   

Abstract

It is very difficult to treat patients with liver metastasis presenting with jaundice or cachexia. We herein report a successfully treated case of huge liver metastasis of gastrointestinal stromal tumor (GIST) that initially showed jaundice and cachexia. The patient was a woman in her early 40 s. She had a history of duodenal GIST 4 years before this admission. She was admitted to our hospital for abdominal fullness and anorexia. Abdominal computed tomography revealed huge liver metastasis of GIST. She showed jaundice and cancer cachexia with a modified Glasgow Prognostic Score of 2. After applying nutritional support, 400 mg of imatinib was administered. Although leg edema transiently worsened, the withdrawal of imatinib and administration of diuretics improved it. Imatinib was re-administered, and nutritional support was continued. The total bilirubin level decreased, and the serum albumin level increased. The tumor gradually decreased in size. Finally, she received surgical resection after 16 months of treatment with imatinib. Although adjuvant imatinib administration was continued after surgery, and no recurrence was observed as of 18 months after surgery.

Entities:  

Keywords:  Cachexia; Gastrointestinal stromal tumor; Imatinib; Jaundice; Nutritional support

Mesh:

Substances:

Year:  2021        PMID: 33507488     DOI: 10.1007/s12328-021-01340-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  20 in total

1.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Cristina R Antonescu; Ronald P DeMatteo; Kristen N Ganjoo; Robert G Maki; Peter W T Pisters; Chandrajit P Raut; Richard F Riedel; Scott Schuetze; Hema M Sundar; Jonathan C Trent; Jeffrey D Wayne
Journal:  J Natl Compr Canc Netw       Date:  2010-04       Impact factor: 11.908

2.  Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P G Casali; N Abecassis; H T Aro; S Bauer; R Biagini; S Bielack; S Bonvalot; I Boukovinas; J V M G Bovee; T Brodowicz; J M Broto; A Buonadonna; E De Álava; A P Dei Tos; X G Del Muro; P Dileo; M Eriksson; A Fedenko; V Ferraresi; A Ferrari; S Ferrari; A M Frezza; S Gasperoni; H Gelderblom; T Gil; G Grignani; A Gronchi; R L Haas; B Hassan; P Hohenberger; R Issels; H Joensuu; R L Jones; I Judson; P Jutte; S Kaal; B Kasper; K Kopeckova; D A Krákorová; A Le Cesne; I Lugowska; O Merimsky; M Montemurro; M A Pantaleo; R Piana; P Picci; S Piperno-Neumann; A L Pousa; P Reichardt; M H Robinson; P Rutkowski; A A Safwat; P Schöffski; S Sleijfer; S Stacchiotti; K Sundby Hall; M Unk; F Van Coevorden; W T A van der Graaf; J Whelan; E Wardelmann; O Zaikova; J Y Blay
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

3.  Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.

Authors:  Yasuhiro Inoue; Takashi Iwata; Yoshinaga Okugawa; Aya Kawamoto; Junichiro Hiro; Yuji Toiyama; Koji Tanaka; Keiichi Uchida; Yasuhiko Mohri; Chikao Miki; Masato Kusunoki
Journal:  Oncology       Date:  2012-11-09       Impact factor: 2.935

4.  Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.

Authors:  Ramesh K Ramanathan; Merrill J Egorin; Chris H M Takimoto; Scot C Remick; James H Doroshow; Patricia A LoRusso; Daniel L Mulkerin; Jean L Grem; Anne Hamilton; Anthony J Murgo; Douglas M Potter; Chandra P Belani; Michael J Hayes; Bin Peng; S Percy Ivy
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

5.  Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function.

Authors:  Sebastian Bauer; Volker Hagen; Hermann J Pielken; Peter Bojko; Siegfried Seeber; Jochen Schütte
Journal:  Anticancer Drugs       Date:  2002-09       Impact factor: 2.248

6.  Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Authors:  Michael C Heinrich; Christopher L Corless; George D Demetri; Charles D Blanke; Margaret von Mehren; Heikki Joensuu; Laura S McGreevey; Chang-Jie Chen; Annick D Van den Abbeele; Brian J Druker; Beate Kiese; Burton Eisenberg; Peter J Roberts; Samuel Singer; Christopher D M Fletcher; Sandra Silberman; Sasa Dimitrijevic; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

7.  Duodenal GIST: a single center experience.

Authors:  Alexander Beham; Inga-Marie Schaefer; Silke Cameron; Katharina von Hammerstein; Laszlo Füzesi; Giuliano Ramadori; Michael B Ghadimi
Journal:  Int J Colorectal Dis       Date:  2012-02-22       Impact factor: 2.571

8.  Duodenal gastrointestinal stromal tumors: clinicopathological characteristics, surgery, and long-term outcome.

Authors:  Chaoyong Shen; Haining Chen; Yuan Yin; Jiaju Chen; Luyin Han; Bo Zhang; Zhixin Chen; Jiaping Chen
Journal:  BMC Surg       Date:  2015-08-15       Impact factor: 2.102

9.  Small gastrointestinal stromal tumour of the duodenum causing a life-threatening bleeding - A case report and review of the literature.

Authors:  Milena Taskovska; Mirko Omejc; Jan Grosek
Journal:  Int J Surg Case Rep       Date:  2019-03-30

10.  Asymptomatic large duodenal GIST - An incidental finding in abdominopelvic ultrasonography: A case report.

Authors:  Andreia J Santos; André Tojal; Liliana Duarte; Conceição Marques; Luís F Pinheiro; Carlos Casimiro
Journal:  Int J Surg Case Rep       Date:  2020-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.